| Product NDC: | 21695-213 |
| Proprietary Name: | Ambien CR |
| Non Proprietary Name: | zolpidem tartrate |
| Active Ingredient(s): | 12.5 mg/1 & nbsp; zolpidem tartrate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 21695-213 |
| Labeler Name: | Rebel Distributors Corp. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021774 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20090630 |
| Package NDC: | 21695-213-30 |
| Package Description: | 30 TABLET, COATED in 1 BOTTLE (21695-213-30) |
| NDC Code | 21695-213-30 |
| Proprietary Name | Ambien CR |
| Package Description | 30 TABLET, COATED in 1 BOTTLE (21695-213-30) |
| Product NDC | 21695-213 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | zolpidem tartrate |
| Dosage Form Name | TABLET, COATED |
| Route Name | ORAL |
| Start Marketing Date | 20090630 |
| Marketing Category Name | NDA |
| Labeler Name | Rebel Distributors Corp. |
| Substance Name | ZOLPIDEM TARTRATE |
| Strength Number | 12.5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | gamma-Aminobutyric Acid-ergic Agonist [EPC],GABA A Agonists [MoA],Pyridines [Chemical/Ingredient],Central Nervous System Depression [PE] |